Hanoch Rappaport
Directeur Général chez Provident Fund of the Hebrew University of Jerusalem Ltd.
Postes actifs de Hanoch Rappaport
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| The Hebrew University of Jerusalem | Corporate Officer/Principal | - | - |
| Provident Fund of the Hebrew University of Jerusalem Ltd. | Directeur Général | 01/01/2014 | - |
| Directeur Financier/CFO | 01/05/2005 | 01/01/2014 |
Historique de carrière de Hanoch Rappaport
Anciens postes connus de Hanoch Rappaport
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Directeur/Membre du Conseil | 01/01/2006 | 01/11/2013 |
| ANCHIANO THERAPEUTICS LTD. | Directeur/Membre du Conseil | 01/01/2006 | - |
| A. Heifetz & Co. | Directeur en chef des Investissements | - | - |
| BANK HAPOALIM B.M. | Corporate Officer/Principal | - | - |
Formation de Hanoch Rappaport
| Bar-Ilan University | Undergraduate Degree |
| Tel-Aviv University | Masters Business Admin |
| The Hebrew University of Jerusalem | Masters Business Admin |
Statistiques
Internationale
| Israël | 7 |
| Etats-Unis | 3 |
Opérationnelle
| Director/Board Member | 2 |
| Masters Business Admin | 2 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
| Finance | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BANK HAPOALIM B.M. | Finance |
| Entreprise privées | 4 |
|---|---|
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
| A. Heifetz & Co. | |
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. | Health Technology |
| Provident Fund of the Hebrew University of Jerusalem Ltd. | Finance |
- Bourse
- Insiders
- Hanoch Rappaport
- Expérience
